135 related articles for article (PubMed ID: 10568863)
1. Plasma levels of substance P, neuropeptide Y and vasoactive intestinal polypeptide in patients with chronic tension-type headache.
Ashina M; Bendtsen L; Jensen R; Ekman R; Olesen J
Pain; 1999 Dec; 83(3):541-547. PubMed ID: 10568863
[TBL] [Abstract][Full Text] [Related]
2. Plasma levels of calcitonin gene-related peptide in chronic tension-type headache.
Ashina M; Bendtsen L; Jensen R; Schifter S; Jansen-Olesen I; Olesen J
Neurology; 2000 Nov; 55(9):1335-40. PubMed ID: 11087777
[TBL] [Abstract][Full Text] [Related]
3. Absence of vasoactive peptide release from brain to cerebral circulation during onset of migraine with aura.
Friberg L; Olesen J; Olsen TS; Karle A; Ekman R; Fahrenkrug J
Cephalalgia; 1994 Feb; 14(1):47-54. PubMed ID: 7515329
[TBL] [Abstract][Full Text] [Related]
4. Plasma concentration of selected neuropeptides in patients suffering from psoriasis.
Reich A; Orda A; Wiśnicka B; Szepietowski JC
Exp Dermatol; 2007 May; 16(5):421-8. PubMed ID: 17437485
[TBL] [Abstract][Full Text] [Related]
5. Expression of messenger ribonucleic acids encoding neuropeptide-Y, substance-P, and vasoactive intestinal polypeptide in human pituitary.
Byrne JM; Jones PM; Hill SF; Bennet WM; Ghatei MA; Bloom SR
J Clin Endocrinol Metab; 1992 Oct; 75(4):983-7. PubMed ID: 1383256
[TBL] [Abstract][Full Text] [Related]
6. Alterations in perivascular dilatory neuropeptides (CGRP, SP, VIP) in the external jugular vein and in the cerebrospinal fluid following subarachnoid haemorrhage in man.
Juul R; Hara H; Gisvold SE; Brubakk AO; Fredriksen TA; Waldemar G; Schmidt JF; Ekman R; Edvinsson L
Acta Neurochir (Wien); 1995; 132(1-3):32-41. PubMed ID: 7538726
[TBL] [Abstract][Full Text] [Related]
7. Low plasma concentrations of VIP and elevated levels of other neuropeptides during exacerbations of asthma.
Cardell LO; Uddman R; Edvinsson L
Eur Respir J; 1994 Dec; 7(12):2169-73. PubMed ID: 7713199
[TBL] [Abstract][Full Text] [Related]
8. Circulating levels of neuropeptides (CGRP, VIP, NPY) in patients with fulminant hepatic failure.
Strauss GI; Edvinsson L; Larsen FS; Møller K; Knudsen GM
Neuropeptides; 2001; 35(3-4):174-80. PubMed ID: 11884208
[TBL] [Abstract][Full Text] [Related]
9. Plasma neuropeptides in hyperthyroidism.
Erfurth EM; Ekman R; Ahrén B
Thyroidology; 1990 Aug; 2(2):59-63. PubMed ID: 1724911
[TBL] [Abstract][Full Text] [Related]
10. Neuropeptide variability in man.
Onuoha GN; Nugent AM; Hunter SJ; Alpar EK; McEneaney DJ; Campbell NP; Shaw C; Buchanan KD; Nicholls DP
Eur J Clin Invest; 2000 Jul; 30(7):570-7. PubMed ID: 10886296
[TBL] [Abstract][Full Text] [Related]
11. Effects of ischaemia and reperfusion on vasoactive neuropeptide levels in the canine infrarenal aortic revascularization model.
Dovgan PS; Edwards JD; Rowley JM; Agrawal DK; Adrian TE
Cardiovasc Surg; 1996 Aug; 4(4):470-5. PubMed ID: 8866083
[TBL] [Abstract][Full Text] [Related]
12. Vasoactive peptide release in the extracerebral circulation of humans during migraine headache.
Goadsby PJ; Edvinsson L; Ekman R
Ann Neurol; 1990 Aug; 28(2):183-7. PubMed ID: 1699472
[TBL] [Abstract][Full Text] [Related]
13. Neuropeptide chronomics in clinically healthy young adults: circaoctohoran and circadian patterns.
Löckinger A; Köberle D; König PS; Saria A; Herold M; Cornélissen G; Halberg F
Peptides; 2004 Apr; 25(4):533-42. PubMed ID: 15165707
[TBL] [Abstract][Full Text] [Related]
14. Human in vivo evidence for trigeminovascular activation in cluster headache. Neuropeptide changes and effects of acute attacks therapies.
Goadsby PJ; Edvinsson L
Brain; 1994 Jun; 117 ( Pt 3)():427-34. PubMed ID: 7518321
[TBL] [Abstract][Full Text] [Related]
15. Patterns of neuronal colocalisation of tyrosine hydroxylase, neuropeptide Y, vasoactive intestinal polypeptide, calcitonin gene-related peptide and substance P in human ureter.
Edyvane KA; Smet PJ; Trussell DC; Jonavicius J; Marshall VR
J Auton Nerv Syst; 1994 Aug; 48(3):241-55. PubMed ID: 7525686
[TBL] [Abstract][Full Text] [Related]
16. Distribution of vasoactive intestinal polypeptide, neuropeptide-Y and substance P and their effects on insulin secretion from the in vitro pancreas of normal and diabetic rats.
Adeghate E; Ponery AS; Pallot DJ; Singh J
Peptides; 2001 Jan; 22(1):99-107. PubMed ID: 11179603
[TBL] [Abstract][Full Text] [Related]
17. Perivascular neuropeptides (NPY, VIP, CGRP and SP) in human brain vessels after subarachnoid haemorrhage.
Edvinsson L; Juul R; Jansen I
Acta Neurol Scand; 1994 Nov; 90(5):324-30. PubMed ID: 7534026
[TBL] [Abstract][Full Text] [Related]
18. Multiple effects of neuropeptide Y, substance P and vasoactive intestinal polypeptide on progesterone and oxytocin release from bovine corpus luteum in vitro.
Miyamoto A; Brückmann A; von Lützow H; Schams D
J Endocrinol; 1993 Sep; 138(3):451-8. PubMed ID: 7506290
[TBL] [Abstract][Full Text] [Related]
19. Many peptides that are present in the external zone of the median eminence are not secreted into the hypophysial portal blood of sheep.
Clarke I; Jessop D; Millar R; Morris M; Bloom S; Lightman S; Coen CW; Lew R; Smith I
Neuroendocrinology; 1993 May; 57(5):765-75. PubMed ID: 7692337
[TBL] [Abstract][Full Text] [Related]
20. Differential response of neuropeptide Y, substance P and vasoactive intestinal polypeptide in the rat anterior pituitary gland to alterations in thyroid hormone status.
Jones PM; Ghatei MA; Wallis SC; Bloom SR
J Endocrinol; 1994 Nov; 143(2):393-7. PubMed ID: 7530290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
